Insiders Trades

★ Sign in to follow

WP

William Panenka

Abattis Bioceuticals Corp.

Cumul. flow

Total declarations

22

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (15 ops.)

€372k

Latest filing published 22 Jan 2018 for Abattis Bioceuticals Corp., €35k.

Filing timeline

BuySale

William Panenka

Insider track record

Disclosed buys

0

Disclosed sells

15

Signal history

William Panenka: trading record in brief

All filings by William Panenka on record concern Abattis Bioceuticals Corp. In total, 22 filings cover trades dated from 2 November 2016 to 19 January 2018.

The open-market record consists of 15 sales worth €372k, with no purchase. Other entries cover 4 share grants and 2 option exercises. So far in 2018, the count stands at no purchases and 9 sales.

The latest filing, published on 22 January 2018, reports an open-market sale of €35k in Abattis Bioceuticals Corp. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to William Panenka

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Abattis Bioceuticals Corp. (CA)

Declarations22 total

▼

William Panenka

4 - Director of IssuerExecutives18 Jan 2018Abattis Bioceuticals Corp.

53,100 CAD12SEDI

90,000 shares@ CA$0.597.7% of flowCommon SharesTSXSEDI:3121622

▼

William Panenka

4 - Director of IssuerExecutives19 Jan 2018Abattis Bioceuticals Corp.

53,100 CAD12SEDI

90,000 shares@ CA$0.597.7% of flowCommon SharesTSXSEDI:3121623

▼

William Panenka

4 - Director of IssuerExecutives16 Jan 2018Abattis Bioceuticals Corp.

16,750 CAD11SEDI

25,000 shares@ CA$0.672.4% of flowCommon SharesTSXSEDI:3120373

▼

William Panenka

4 - Director of IssuerExecutives16 Jan 2018Abattis Bioceuticals Corp.

43,771 CAD12SEDI

65,000 shares@ CA$0.67346.3% of flowCommon SharesTSXSEDI:3120372

▼

William Panenka

4 - Director of IssuerExecutives11 Jan 2018Abattis Bioceuticals Corp.

36,000 CAD12SEDI

60,000 shares@ CA$0.605.3% of flowCommon SharesTSXSEDI:3118909

▼

William Panenka

4 - Director of IssuerExecutives11 Jan 2018Abattis Bioceuticals Corp.

18,300 CAD11SEDI

30,000 shares@ CA$0.612.7% of flowCommon SharesTSXSEDI:3118910

▼

William Panenka

4 - Director of IssuerExecutives12 Jan 2018Abattis Bioceuticals Corp.

47,700 CAD12SEDI

90,000 shares@ CA$0.536.9% of flowCommon SharesTSXSEDI:3118912

▼

William Panenka

4 - Director of IssuerExecutives15 Jan 2018Abattis Bioceuticals Corp.

53,100 CAD12SEDI

90,000 shares@ CA$0.597.7% of flowCommon SharesTSXSEDI:3118913

▼

William Panenka

4 - Director of IssuerExecutives12 Jan 2018Abattis Bioceuticals Corp.

48,042 CAD12SEDI

90,000 shares@ CA$0.53387.0% of flowCommon SharesTSXSEDI:3118911

▼

William Panenka

4 - Director of IssuerExecutives12 Dec 2017Abattis Bioceuticals Corp.

48,000 CAD12SEDI

100,000 shares@ CA$0.485.9% of flowCommon SharesTSXSEDI:3098041

▼

William Panenka

4 - Director of IssuerExecutives12 Dec 2017Abattis Bioceuticals Corp.

50,000 CAD12SEDI

100,000 shares@ CA$0.506.1% of flowCommon SharesTSXSEDI:3098033

▼

William Panenka

4 - Director of IssuerExecutives12 Dec 2017Abattis Bioceuticals Corp.

27,000 CAD11SEDI

50,000 shares@ CA$0.543.3% of flowCommon SharesTSXSEDI:3098038

◆

William Panenka

4 - Director of IssuerExecutives12 Jun 2017Abattis Bioceuticals Corp.

92,500 CAD15SEDI

500,000 shares@ CA$0.18536.3% of flowCommon SharesTSXSEDI:3021560

▼

William Panenka

4 - Director of IssuerExecutives13 Apr 2017Abattis Bioceuticals Corp.

21,315 CAD12SEDI

73,500 shares@ CA$0.298.8% of flowCommon SharesTSXSEDI:2997223

◆

William Panenka

4 - Director of IssuerExecutives5 Apr 2017Abattis Bioceuticals Corp.

75,000 CAD14SEDI

500,000 shares@ CA$0.1530.6% of flowCommon SharesTSXSEDI:2994914

◆

William Panenka

4 - Director of IssuerExecutives24 Mar 2017Abattis Bioceuticals Corp.

60,000 CAD13SEDI

500,000 shares@ CA$0.1224.4% of flowCommon SharesTSXSEDI:2984668

◇

William Panenka

4 - Director of IssuerExecutives18 Jan 2017Abattis Bioceuticals Corp.

0SEDI

200,000 sharesCommon SharesTSXSEDI:2948977

▼

William Panenka

4 - Director of IssuerExecutives9 Jan 2017Abattis Bioceuticals Corp.

28,000 CAD11SEDI

200,000 shares@ CA$0.144.4% of flowCommon SharesTSXSEDI:2944827

▼

William Panenka

4 - Director of IssuerExecutives25 Nov 2016Abattis Bioceuticals Corp.

14,500 CAD11SEDI

100,000 shares@ CA$0.1452.2% of flowCommon SharesTSXSEDI:2920543

◆

William Panenka

4 - Director of IssuerExecutives14 Nov 2016Abattis Bioceuticals Corp.

0SEDI

100,000 sharesCommon SharesTSXSEDI:2914156

●

William Panenka

4 - Director of IssuerExecutives2 Nov 2016Abattis Bioceuticals Corp.

0SEDI

Common SharesTSXSEDI:2914155

◇

William Panenka

4 - Director of IssuerExecutives15 Nov 2016Abattis Bioceuticals Corp.

14,000 CAD11SEDI

200,000 shares@ CA$0.072.1% of flowCommon SharesTSXSEDI:2914161

22 of 22 declarations